SPHERA FUNDS MANAGEMENT LTD. - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 166 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2017$1,347,000
+108.5%
300,000
+357.7%
0.19%
+186.6%
Q1 2015$646,000
-58.0%
65,538
-47.8%
0.07%
-74.4%
Q4 2014$1,538,000
+35.4%
125,538
-16.3%
0.26%
-6.4%
Q2 2014$1,136,000150,0000.28%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q2 2015
NameSharesValueWeighting ↓
RA Capital Management 12,033,220$92,896,00011.87%
RTW INVESTMENTS, LP 2,558,859$19,754,0007.17%
TURNER INVESTMENTS LLC 859,560$6,636,0001.80%
DAFNA Capital Management LLC 236,500$1,826,0001.58%
Ghost Tree Capital, LLC 250,000$1,930,0001.09%
Orbimed Advisors 11,519,700$88,932,0000.94%
Rock Springs Capital Management LP 1,220,000$9,418,0000.79%
Opus Point Partners Management, LLC 99,000$764,0000.59%
Bellevue Group AG 420,000$3,242,0000.59%
Cormorant Asset Management, LP 500,000$3,860,0000.58%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders